$16.70▲0.80 (5.03%)
After Hours:$16.78+0.08 (+0.48%)· 4:30 PM ET
Ultragenyx Pharmaceutical Inc. (RARE)
Operating Cash Flow (Statement)
-$436.83M
TTM · Period ending: · USD

RARE Operating Cash Flow (Statement)
Latest reported-$436.83Mperiod ending
Latest reported-$436.83Mperiod ending
RARE Cash from Operations (-$5.83M → -$436.83M)
Annual operating cash flow (statement)
High-resolution chart · PNG
What is operating cash flow (statement)?
Net cash provided by operating activities.
RARE operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -466,000,000 | |
| -414,188,000 | |
| -474,806,000 | |
| -380,465,000 | |
| -338,695,000 | |
| -132,220,000 | |
| -345,383,000 | |
| -290,566,000 | |
| -253,843,000 | |
| -160,975,000 | |
| -105,977,000 | |
| -44,634,000 | |
| -31,200,000 | |
| -12,504,000 | |
| -5,825,000 |
Explore More
RARE Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance